NutriSystem (NASDAQ: NTRI) and Cannabis Sativa (OTCMKTS:CBDS) are both small-cap non-cyclical consumer goods services companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, earnings, profitability, dividends, risk and institutional ownership.
NutriSystem has a beta of 1.01, suggesting that its stock price is 1% more volatile than the SP 500. Comparatively, Cannabis Sativa has a beta of -7.47, suggesting that its stock price is 847% less volatile than the SP 500.
This table compares NutriSystem and Cannabis Sativa’s net margins, return on equity and return on assets.
This is a breakdown of recent ratings and target prices for NutriSystem and Cannabis Sativa, as reported by MarketBeat.com.
NutriSystem currently has a consensus price target of $68.75, suggesting a potential upside of 29.47%. Given NutriSystem’s higher probable upside, research analysts plainly believe